Additionally, our bioinformatic analyses of microarray data from NB tumors unveiled a correlation between high ESR1 expression and enhanced event-free survival in NB patients, indicating a favorable disease outcome (refer to Figure 3N). This evidence concerns the gene ESR1 and neuroblastoma.